Utilizing a Next Generation Sequencing Platform to Investigate Patterns of Chromosome Arm Loss and Gain in Rare Hypomtuated Tumors.
View/ Open
Thesis_Final_Russell_William_Madison_2020 (1).pdf (2.185Mb)(embargoed until: 2025-05-31)
Author
Madison, Russell William
Metadata
Show full item recordCitation
Madison, Russell William. 2021. Utilizing a Next Generation Sequencing Platform to Investigate Patterns of Chromosome Arm Loss and Gain in Rare Hypomtuated Tumors.. Master's thesis, Harvard University Division of Continuing Education.Abstract
Chromosome aneuploidies are the most pervasive genomic aberration seen in cancer. Despite this, much is still unknown about the cellular mechanisms that cause these genomic events and their prognostic value across cancer types. Rare tumors are often overlooked in large clinical trials due to difficulties accruing patients and limited understanding of the cellular biology of these understudied diseases. Initial work in esthesioneuroblastoma (ENB), a rare tumor which generally lack genomic alterations and originate from nerve cells in the naval cavity, identified three subtypes defined by unique patterns of aneuploidies. This led to the hypothesis that other rare tumors lacking genomic alterations may similarly be defined by aneuploidies, rather than other classes of genomic alterations. This study presents exploratory analysis on several rare cancers with the aim of identifying and describing subtypes which are defined by distinct patterns of aneuploidies.Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37367678
Collections
- DCE Theses and Dissertations [1331]
Contact administrator regarding this item (to report mistakes or request changes)